Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Respiratory
Respiratory
Bayer for ProfessionalsYour Resource Portal
Events & Webinars

BOPA 2021: A practical look at service optimisation in non-metastatic castration-resistant (nmCRPC) prostate cancer

Nubeqa Header Image

Description

The Bayer sponsored video at the British Oncology Pharmacy Association 24th Annual Symposium was hosted by Simon Shepherd, Pharmacist, Engagement & Educational Manager – Oncology, Bayer, who interviewed Robert Duncombe, Chief Pharmacist, The Royal Marsden and Junaid Mobeen, Specialist Clinical Pharmacist Practitioner, Nottingham University Hospital. This discussion focussed on the evolving treatment landscape in nmCRPC, and the role of the pharmacist in the management of nmCRPC patients including how the role of the pharmacist can be extended to address capacity issues within the NHS.

NUBEQA▼ GB Prescribing Information
NUBEQA▼ NI Prescribing Information

Speakers
    • robert_duncombeRobert Duncombe

    Rob Duncombe is the Clinical Director of Pharmacy at the Royal Marsden in London and chair of the Royal Pharmaceutical Society Hospital Expert Advisory Group. He is an experienced hospital pharmacist and chief of pharmacy in the NHS, having previously worked as the director of pharmacy at The Christie NHS Foundation trust and worked for seven years as chief pharmacist at the Princess Alexandra hospital in Harlow, Essex.

    • junaid_mobeenJunaid Mobeen

    Junaid Mobeen is the Lead Oncology Pharmacist at Nottingham University Hospitals and runs a pharmacy-led service for prostate cancer patients including remote patient monitoring.

P3 Prostate Cancer Forum: Series Overview
NUBEQA®▼ (darolutamide) | Xofigo®▼ (radium-223 dichloride)
PP-NUB-GB-1318, February 2024
ASCO-GU 2023: The DEAR study in nmCRPC
NUBEQA®▼ (darolutamide)
PP-NUB-GB-1296, February 2024
BAUS 2022: Navigating treatment decisions in nmCRPC patients
NUBEQA®▼ (darolutamide)
PP-NUB-GB-1298, February 2024

PP-NUB-GB-1299 | February 2024